{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:11:32Z","timestamp":1768543892192,"version":"3.49.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["DA12867"],"award-info":[{"award-number":["DA12867"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["DA 19107"],"award-info":[{"award-number":["DA 19107"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.pharmthera.2005.08.004","type":"journal-article","created":{"date-parts":[[2005,9,9]],"date-time":"2005-09-09T11:51:53Z","timestamp":1126266713000},"page":"246-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs"],"prefix":"10.1016","volume":"109","author":[{"given":"Yossef","family":"Itzhak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed F.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.08.004_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(94)90033-7","article-title":"Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens","volume":"643","author":"Abekawa","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01271227","article-title":"Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain","volume":"103","author":"Abekawa","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.npp.1300675","article-title":"Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice","volume":"30","author":"Achat-Mendes","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0892-0362(93)90067-X","article-title":"Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate","volume":"15","author":"Ali","year":"1993","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(09)90007-5","article-title":"Low environmental temperatures of pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice","volume":"658","author":"Ali","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1089-8603(03)00046-6","article-title":"Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA (\u2018Ecstasy\u2019) and p-chloroamphetamine in mice","volume":"9","author":"Anderson","year":"2003","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/syn.890090405","article-title":"Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain","volume":"9","author":"Axt","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib8","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1523\/JNEUROSCI.22-06-02135.2002","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity","volume":"22","author":"Battaglia","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20689-9","article-title":"Effects of cocaine and related drugs in nonhuman primates: III. Self-administration by squirrel monkeys","volume":"251","author":"Bergman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib11","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.51.6.1532","article-title":"Memory impairment in abstinent MDMA (\u201cEcstasy\u201d) users","volume":"51","author":"Bolla","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","article-title":"Nitric oxide: a physiologic messenger molecule","volume":"63","author":"Bredt","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0959-4388(97)80065-7","article-title":"Synaptic signaling by nitric oxide","volume":"7","author":"Brenman","year":"1997","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib14","first-page":"375","article-title":"Long-term effects of \u201cEcstasy\u201d use on serotonin transporters of the brain investigated by PET","volume":"44","author":"Buchert","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.03-0073rev","article-title":"Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis","volume":"17","author":"Cadet","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib16","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1097\/00001756-199808240-00001","article-title":"Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity","volume":"9","author":"Callahan","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3565(25)12637-2","article-title":"Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats","volume":"254","author":"Callaway","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib18","first-page":"113","article-title":"Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3, 4-methylenedioxymethamphetamine","volume":"7","author":"Callaway","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d): psychomotor performance and subjective effects","volume":"20","author":"Cami","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-8993(94)90523-1","article-title":"The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats","volume":"668","author":"Camp","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00429-003-0355-0","article-title":"Dopaminergic modulation of nNOS expression in the pituitary gland of the rat","volume":"207","author":"Carretero","year":"2003","journal-title":"Anat Embryol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/REVNEURO.2003.14.3.207","article-title":"Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity","volume":"14","author":"Centonze","year":"2003","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib24","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent on the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0925-4927(02)00004-5","article-title":"Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users","volume":"114","author":"Chang","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.bjp.0704435","article-title":"A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019) on dopamine neurons in mouse brain","volume":"134","author":"Colado","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0893-133X(00)00238-4","article-title":"The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding","volume":"24","author":"Crombag","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-004-1798-6","article-title":"Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys","volume":"175","author":"Czoty","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.pbb.2004.01.008","article-title":"Effect of SCH 23390 on (+\/\u2212)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats","volume":"77","author":"Daniela","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/jpet.104.074849","article-title":"Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain","volume":"312","author":"Darvesh","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment","volume":"36","author":"Davidson","year":"2001","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib32","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1523\/JNEUROSCI.16-08-02479.1996","article-title":"Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice","volume":"16","author":"Dawson","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(99)02087-9","article-title":"Methamphetamine administration causes overexpression of nNOS in the mouse striatum","volume":"851","author":"Deng","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1460-9568.2000.00927.x","article-title":"NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis","volume":"12","author":"de Vente","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(02)00286-3","article-title":"Nucleus accumbens shell and core dopamine: differential role in behavior and addiction","volume":"137","author":"Di Chiara","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib36","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib37","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1046\/j.1471-4159.1996.67062443.x","article-title":"Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase","volume":"67","author":"Di Monte","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-0173(01)00088-1","article-title":"The neuropsychological basis of addictive behaviour","volume":"36","author":"Everitt","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00213-002-1021-6","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement","volume":"161","author":"Fantegrossi","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1261-5","article-title":"Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice","volume":"166","author":"Fantegrossi","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib41","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.npp.1300442","article-title":"Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys","volume":"29","author":"Fantegrossi","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1081\/CLT-100102011","article-title":"A profile of methylphenidate exposures","volume":"38","author":"Foley","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-8993(91)90609-Y","article-title":"5,7-Dihydroxytryptamine injections increase glial fibrillary acid protein in the hypothalamus of adult rats","volume":"549","author":"Frankfurt","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00969891","article-title":"Effect of p-chloroamphetamine on brain serotonin neurons","volume":"7","author":"Fuller","year":"1992","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib45","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1073\/pnas.87.9.3547","article-title":"The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system","volume":"87","author":"Gally","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.ph.57.030195.003343","article-title":"Nitric oxide signaling in the central nervous system","volume":"57","author":"Garthwaite","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/336385a0","article-title":"Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain","volume":"336","author":"Garthwaite","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib48","first-page":"317","article-title":"Neurochemical basis of neurotoxicity","volume":"11","author":"Gibb","year":"1990","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainresbull.2003.08.010","article-title":"Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase","volume":"62","author":"Gomez","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib51","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","article-title":"Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons","volume":"2","author":"Hantraye","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130100738","article-title":"Methamphetamine self-administration by humans","volume":"157","author":"Hart","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)30227-2","article-title":"Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex","volume":"194","author":"Heikkila","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib54","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0092-8674(93)90615-W","article-title":"Targeted disruption of the neuronal nitric oxide synthase gene","volume":"75","author":"Huang","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0006-8993(99)02249-0","article-title":"Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation","volume":"855","author":"Imam","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(99)01663-7","article-title":"Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst","volume":"837","author":"Imam","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1471-4159.2001.00029.x","article-title":"Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase","volume":"76","author":"Imam","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0028-3908(93)90072-B","article-title":"Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice","volume":"32","author":"Itzhak","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0028-3908(96)00037-8","article-title":"Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase","volume":"35","author":"Itzhak","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-3565(24)36836-3","article-title":"Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase","volume":"282","author":"Itzhak","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/15216540410001727699","article-title":"Methamphetamine and MDMA (Ecstasy) neurotoxicity: \u2018of mice and men\u2019","volume":"56","author":"Itzhak","year":"2004","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib62","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1046\/j.1471-4159.1996.67041770.x","article-title":"The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo","volume":"67","author":"Itzhak","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0006-8993(00)01940-5","article-title":"Blockage of alcohol-induced locomotor sensitization and conditioned place preference in DBA mice by 7-nitroindazole","volume":"858","author":"Itzhak","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00008877-200202000-00008","article-title":"Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on methylphenidate-induced hyperlocomotion in mice","volume":"13","author":"Itzhak","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0893-133X(01)00303-7","article-title":"Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants","volume":"26","author":"Itzhak","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib66","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s002130050779","article-title":"Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization","volume":"140","author":"Itzhak","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib67","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0022-3565(24)37339-2","article-title":"Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity","volume":"284","author":"Itzhak","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib68","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1097\/00001756-199808030-00011","article-title":"The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference","volume":"9","author":"Itzhak","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<305::AID-SYN6>3.0.CO;2-#","article-title":"Methamphetamine- and 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice","volume":"34","author":"Itzhak","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib70","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1097\/00001756-200009110-00022","article-title":"nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice","volume":"11","author":"Itzhak","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.2003.02023.x","article-title":"Fenfluramine-induced serotonergic neurotoxicity in mice: lack of neuroprotection by inhibition\/ablation of nNOS","volume":"87","author":"Itzhak","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-002-1320-y","article-title":"Relevance of MDMA (\u201cEcstasy\u201d)-induced neurotoxicity to long-lasting psychomotor stimulation in mice","volume":"166","author":"Itzhak","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1316.015","article-title":"Differential response of nNOS knockout mice to MDMA (\u201cEcstasy\u201d)- and methamphetamine-induced psychomotor sensitization and neurotoxicity","volume":"1025","author":"Itzhak","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0028-3908(03)00316-2","article-title":"Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice","volume":"46","author":"Itzhak","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)94090-K","article-title":"Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine","volume":"191","author":"Johnson","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(89)90045-3","article-title":"Blockade of \u201creverse tolerance\u201d to cocaine and amphetamine by MK-801","volume":"45","author":"Karler","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib77","first-page":"677","article-title":"Methamphetamine-induced dopamine release in the medial frontal cortex of freely moving rats","volume":"45","author":"Kashihara","year":"1991","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuron.2004.09.016","article-title":"Memory and addiction: shared neural circuitry and molecular mechanisms","volume":"44","author":"Kelley","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-2236(00)01745-8","article-title":"Nitric oxide: a novel link between synaptic and nonsynaptic transmission","volume":"24","author":"Kiss","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib81","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(99)00019-4","article-title":"A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum","volume":"34","author":"Kiss","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1254\/jphs.92.178","article-title":"Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption","volume":"92","author":"Kita","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00008480-200204000-00013","article-title":"Abuse and toxicity of methylphenidate","volume":"14","author":"Klein-Schwartz","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib84","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00004583-200303000-00008","article-title":"Poison centers' experience with methylphenidate abuse in preteens and adolescents","volume":"42","author":"Klein-Schwartz","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(89)90700-2","article-title":"Evidence that both intragastric and subcutaneous administration of methylenedioxymethamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys","volume":"488","author":"Kleven","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(76)90090-X","article-title":"Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels","volume":"36","author":"Kogan","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib87","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effect of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib88","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib89","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1523\/JNEUROSCI.19-23-10289.1999","article-title":"Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration","volume":"19","author":"Kuhn","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib90","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","article-title":"Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss","volume":"73","author":"La Voie","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0092-8674(02)00962-5","article-title":"Dual regulation of NMDA receptor functions by direct protein\u2013protein interactions with the dopamine D1 receptor","volume":"111","author":"Lee","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(99)00805-8","article-title":"Systemic administration of d-amphetamine induced a delayed production of nitric oxide in the striatum of rats","volume":"276","author":"Lin","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib93","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1046\/j.1471-4159.1994.63062108.x","article-title":"Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes","volume":"63","author":"Lonart","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0173(03)00173-5","article-title":"Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms","volume":"42","author":"Lyles","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib95","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-8993(97)00517-9","article-title":"Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles","volume":"765","author":"Malberg","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib96","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","article-title":"Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat","volume":"18","author":"Malberg","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(95)00205-7","article-title":"Reinforcing effects of certain serotonin-releasing amphetamine derivatives","volume":"53","author":"Marona-Lewicka","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib98","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00001756-200004070-00010","article-title":"7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion","volume":"11","author":"Martin","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib99","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neubiorev.2003.11.003","article-title":"Amphetamine neurotoxicity: accomplishments and remaining challenges","volume":"27","author":"McCann","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)38720-3","article-title":"Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated","volume":"269","author":"McCann","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib101","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(98)04329-3","article-title":"Positron emission tomographic evidence of toxic effect of MDMA (\u201cEcstasy\u201d) on brain serotonin neurons in human beings","volume":"252","author":"McCann","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib102","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00213-004-1791-0","article-title":"Chronic MDMA (Ecstasy) use, cognition and mood","volume":"173","author":"McCardle","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib104","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0022-3565(24)29412-X","article-title":"Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists","volume":"298","author":"Meririnne","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0304-3940(02)00821-2","article-title":"Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine (\u2018Ecstasy\u2019) and 3,4-methylenedioxy-ethylamphetamine (\u2018Eve\u2019) measured by conditioned place preference in rats","volume":"330","author":"Meyer","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib106","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(25)22434-X","article-title":"Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL\/6J mouse","volume":"270","author":"Miller","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00213-004-1908-5","article-title":"Functional MRI study of working memory in MDMA users","volume":"177","author":"Moeller","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(90)90237-6","article-title":"Anatomic evidence for a neurotoxic effect of (+\/\u2212)-fenfluramine upon serotonergic projections in the rat","volume":"511","author":"Molliver","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib109","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1749-6632.1990.tb16916.x","article-title":"Neurotoxicity of MDMA and related compounds: anatomic studies","volume":"600","author":"Molliver","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib111","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/10673220216223","article-title":"Long-term neuropsychiatric consequences of \u201cEcstasy\u201d (MDMA): a review","volume":"10","author":"Montoya","year":"2002","journal-title":"Harv Rev Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-3223(99)00078-5","article-title":"The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopharmacology of schizophrenia","volume":"46","author":"Moore","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib112","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0028-3908(97)00159-7","article-title":"Dynamic changes in NADPH-diaphorase staining reflect activity in nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release","volume":"36","author":"Morris","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib113","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(92)90713-J","article-title":"Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.","volume":"581","author":"Nash","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib114","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0091-3057(84)90247-8","article-title":"Self-administration of central stimulants by rats: a comparison of the effects of d-amphetamine, methylphenidate and McNeil 4612","volume":"20","author":"Nielsen","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-3565(25)22433-8","article-title":"Neurotoxicity profiles of substituted amphetamines in the C57BL\/6J mouse","volume":"270","author":"O'Callaghan","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib116","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1523\/JNEUROSCI.22-11-04399.2002","article-title":"Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons","volume":"22","author":"Park","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib117","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hup.415","article-title":"Ecstasy\/MDMA attributed problems reported by novice, moderate and heavy recreational users","volume":"17","author":"Parrott","year":"2002","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib118","first-page":"208","article-title":"Shedding new light on the \u201csafe\u201d club drug: methylenedioxymethamphetamine (Ecstasy)-related fatalities","volume":"11","author":"Patel","year":"2004","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib119","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1523\/JNEUROSCI.3922-03.2004","article-title":"Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors","volume":"24","author":"Pei","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib121","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib122","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(02)03489-3","article-title":"Neuronal and inducible nitric oxide synthase immunoreactivity following serotonin depletion","volume":"958","author":"Ramos","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib123","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1097\/00001756-200008210-00003","article-title":"Intravenous self-administration of methamphetamine-heroin (speedball) combinations under a progressive-ratio schedule of reinforcement in rats","volume":"11","author":"Ranaldi","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<107::AID-SYN13>3.0.CO;2-1","article-title":"Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies","volume":"30","author":"Rea","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1517\/14656566.5.6.1313","article-title":"Pharmacological management of attention-deficit hyperactivity disorder","volume":"5","author":"Reeves","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib126","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archpsyc.58.10.901","article-title":"Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or \u201cEcstasy\u201d): preliminary findings","volume":"58","author":"Reneman","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1749-6632.1992.tb24586.x","article-title":"Neurotoxic amphetamine analogues: effects in monkeys and implications for humans","volume":"648","author":"Ricaurte","year":"1992","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1988.03410010059035","article-title":"(+\/\u2212)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates","volume":"260","author":"Ricaurte","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib131","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00210-003-0862-9","article-title":"Study of the behavioural responses related to the potential addictive properties of MDMA in mice","volume":"369","author":"Robledo","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib132","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/syn.10266","article-title":"High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain","volume":"50","author":"Rothman","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90057-T","article-title":"Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions","volume":"624","author":"Rowland","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib134","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1471-4159.2003.01714.x","article-title":"The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum","volume":"85","author":"Sanchez","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib135","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1073\/pnas.97.15.8617","article-title":"Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism","volume":"97","author":"Sasaki","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib136","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002130050819","article-title":"Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor","volume":"141","author":"Scearce-Levie","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib137","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0091-3057(91)90010-Y","article-title":"Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination","volume":"38","author":"Schechter","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib138","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1523\/JNEUROSCI.15-12-08419.1995","article-title":"Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo","volume":"15","author":"Schulz","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib139","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of neuronal nitric oxide synthase protects against MPTP-induced neurotoxicity in mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002100000370","article-title":"Regulatory role of nitric oxide over hippocampal 5-HT release in vivo","volume":"363","author":"Segieth","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib141","first-page":"251","article-title":"Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction","volume":"163","author":"Seiden","year":"1996","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0376-8716(76)90030-2","article-title":"Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys","volume":"1","author":"Seiden","year":"1976","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib143","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.175.1.63","article-title":"Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018Ecstasy\u2019) users","volume":"175","author":"Semple","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib144","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1471-4159.2003.01947.x","article-title":"Role of the nitric oxide\/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study","volume":"86","author":"Serra","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib146","doi-asserted-by":"crossref","first-page":"L51","DOI":"10.1016\/0024-3205(94)00887-6","article-title":"Methamphetamine causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide","volume":"55","author":"Sheng","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib147","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.1996.tb17440.x","article-title":"Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells","volume":"801","author":"Sheng","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib148","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02791072.1986.10472361","article-title":"The background and chemistry of MDMA","volume":"18","author":"Shulgin","year":"1986","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib149","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1096\/fasebj.11.2.9039956","article-title":"The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells","volume":"11","author":"Simantov","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(00)01378-1","article-title":"Nitric oxide modulates N-methyl-d-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat","volume":"291","author":"Smith","year":"2000","journal-title":"Neurosci Lett"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.08.004_bib151","first-page":"22","article-title":"ADHD treatment across the life cycle","volume":"65","author":"Spencer","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib152","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0006-2952(96)00482-0","article-title":"Studies on the mechanism of p-chloroamphetamine neurotoxicity","volume":"52","author":"Sprague","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib153","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.890170310","article-title":"Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux","volume":"17","author":"Stephans","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib154","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/0028-3908(87)90017-7","article-title":"Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats","volume":"26","author":"Stone","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0376-8716(03)00131-5","article-title":"Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis","volume":"71","author":"Stoops","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib156","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0361-9230(86)90119-X","article-title":"Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry","volume":"17","author":"Stromberg","year":"1986","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib157","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-8993(09)90033-6","article-title":"Effect of p-chloroamphetamine administration on monoamine metabolism in the rat nucleus accumbens and locomotor activity: studies with intracerebral dialysis in freely moving rats","volume":"658","author":"Sugita","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib158","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"5","author":"Sulzer","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib159","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3565(24)36495-X","article-title":"Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine","volume":"280","author":"Taraska","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainres.2004.01.090","article-title":"The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat","volume":"1008","author":"Trabace","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib161","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib162","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002130000563","article-title":"Cognitive performance and serotonergic function in users of Ecstasy","volume":"153","author":"Verkes","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib163","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1073\/pnas.93.19.10388","article-title":"Relationship between psychostimulant-induced \u201chigh\u201d and dopamine transporter occupancy","volume":"93","author":"Volkow","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib164","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3565(24)37918-2","article-title":"Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of \u201chigh\u201d","volume":"288","author":"Volkow","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib165","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib166","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib167","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)02128-0","article-title":"Dose-related alteration in nitric oxide synthase mRNA expression induced by amphetamine and the full D1 dopamine receptor agonist SKF-82958 in mouse striatum","volume":"311","author":"Wang","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib168","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hup.670","article-title":"Visuo-spatial working memory deficits in current and former users of MDMA (\u2018Ecstasy\u2019)","volume":"20","author":"Wareing","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib174","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2004.03.010","article-title":"Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine","volume":"75","author":"Wee","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib169","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1152\/jn.2000.83.4.1796","article-title":"Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo","volume":"83","author":"West","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0306-4522(94)90313-1","article-title":"Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo","volume":"62","author":"White","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib171","first-page":"191","article-title":"Cocaine reward and cocaine craving: the role of dopamine in perspective","volume":"145","author":"Wise","year":"1994","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib172","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0301-0082(97)00090-7","article-title":"The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants","volume":"54","author":"Wolf","year":"1998","journal-title":"Prog Neurobiol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2005.08.004_bib173","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuropharm.2004.07.006","article-title":"Psychomotor stimulants and neuronal plasticity","volume":"47","author":"Wolf","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib175","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0091-3057(84)80012-X","article-title":"Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys","volume":"21","author":"Woolverton","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib176","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2002.10399957","article-title":"Correlates of Ecstasy use among tenth graders surveyed through monitoring the future","volume":"34","author":"Yacoubian","year":"2002","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib177","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2190\/RJX5-WRA6-BNG5-Q2TY","article-title":"It's a rave new world: estimating the prevalence and perceived harm of Ecstasy and other drug use among club rave attendees","volume":"33","author":"Yacoubian","year":"2003","journal-title":"J Drug Educ"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib178","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(88)90564-X","article-title":"The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat","volume":"148","author":"Yamamoto","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib179","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.8080500","article-title":"Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity","volume":"263","author":"Zhang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.08.004_bib180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(98)00313-8","article-title":"Role of brain nitric oxide in (+\/\u2212)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats","volume":"795","author":"Zheng","year":"1998","journal-title":"Brain Res"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:48:24Z","timestamp":1759009704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":180,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0163725805001713"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.08.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}